Literature DB >> 6378790

Sympathetic outflow to muscles during treatment of hypertension with metoprolol.

B G Wallin, G Sundlöf, E Strömgren, H Aberg.   

Abstract

Microelectrode recordings of multiunit sympathetic vasoconstrictor activity were made in muscle branches of the peroneal nerve in patients with essential hypertension before and during long-term treatment with the cardioselective beta-adrenergic receptor antagonist metoprolol. Nerve activity was quantified by counting the number of sympathetic bursts in the mean voltage neurogram. Metoprolol treatment lowered blood pressure and heart rate in all subjects. During long-term treatment, nerve activity was reduced both when compared to the level of activity after the first dose of the drug (p less than 0.01) and when compared to the control level before treatment (p less than 0.05). It is suggested that the reduction of sympathetic vasoconstrictor outflow to muscles contributed to the blood pressure reduction.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6378790     DOI: 10.1161/01.hyp.6.4.557

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  16 in total

Review 1.  Sympathetic hyperactivity in chronic kidney disease: pathophysiology and (new) treatment options.

Authors:  Eva E Vink; Rosa L de Jager; Peter J Blankestijn
Journal:  Curr Hypertens Rep       Date:  2013-04       Impact factor: 5.369

2.  Increase of renal sympathetic nerve activity by metoprolol or propranolol in conscious spontaneously hypertensive rats.

Authors:  S Majcherczyk; A Mikulski; M Sjölander; P Thorén
Journal:  Br J Pharmacol       Date:  1987-08       Impact factor: 8.739

Review 3.  Cardiovascular Autonomic Dysfunction in Chronic Kidney Disease: a Comprehensive Review.

Authors:  Ibrahim M Salman
Journal:  Curr Hypertens Rep       Date:  2015-08       Impact factor: 5.369

4.  Tachycardia: The hidden cardiovascular risk factor in uncomplicated arterial hypertension.

Authors:  Katarzyna Cierpka-Kmieć; Dagmara Hering
Journal:  Cardiol J       Date:  2019-02-25       Impact factor: 2.737

Review 5.  Sympathetic neural mechanisms in human blood pressure regulation.

Authors:  Emma C Hart; Nisha Charkoudian
Journal:  Curr Hypertens Rep       Date:  2011-06       Impact factor: 5.369

6.  Therapeutic strategies for targeting excessive central sympathetic activation in human hypertension.

Authors:  James P Fisher; Paul J Fadel
Journal:  Exp Physiol       Date:  2010-03-19       Impact factor: 2.969

7.  The I1-imidazoline agonist moxonidine decreases sympathetic tone under physical and mental stress.

Authors:  René R Wenzel; Anna Mitchell; Winfried Siffert; Sandra Bührmann; Thomas Philipp; Rafael F Schäfers
Journal:  Br J Clin Pharmacol       Date:  2004-05       Impact factor: 4.335

8.  Long-term variability and reproducibility of resting human muscle nerve sympathetic activity at rest, as reassessed after a decade.

Authors:  J Fagius; B G Wallin
Journal:  Clin Auton Res       Date:  1993-06       Impact factor: 4.435

9.  Responses to mental stress and physical provocations before and during long term treatment of hypertensive patients with beta-adrenoceptor blockers or hydrochlorothiazide.

Authors:  K Eliasson; T Kahan; B Hylander; P Hjemdahl
Journal:  Br J Clin Pharmacol       Date:  1987-07       Impact factor: 4.335

10.  Effect of stellate ganglionectomy on basal cardiovascular function and responses to beta1-adrenoceptor blockade in the rat.

Authors:  Misa Yoshimoto; Erica A Wehrwein; Martin Novotny; Greg M Swain; David L Kreulen; John W Osborn
Journal:  Am J Physiol Heart Circ Physiol       Date:  2008-10-17       Impact factor: 4.733

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.